Please try another search
Sanjivani Paranteral Limited operates as a pharmaceutical company in India. It offers oral solids, small volume parenterals, and sterile powder formulations. The company’s products include antibiotic, anti-emetic, NSAID and analgesic, anti-malarial, calcium and vitamin, sedative, steroid, cardiovascular, anti-fibrinolytic, muscle relaxant, anti-coagulant, vasoconstrictor, inotropic agent, anti-spasmodic, multi vitamin, iron, antidiabetic, anti-fungal, anti-convulsant, anti-motility, cold, proton pump inhibitor and H2 receptor antagonist, diuretic, anti-gout, anti-viral, and erectile dysfunction products. It offers nutrisan and sanplat capsules; sanclav 625, lizosan, and tydol nutrisol 4k tablets; and solo, nimusan, dedron, santacid, and nimusan plus. In addition, the company offers injections, such as sanofer, sanclin, broadcef, cefrobactum, dorinem, penem, santaz, diclonip, dedron, and sanxamic injections. It exports its products to approximately 25 countries. The company was incorporated in 1994 and is based in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Ashwani A. Khemka | 51 | 1994 | Chairman & MD |
Monika Amit Singhania | 48 | 2022 | Independent Director |
Mrunmai Mahendra Sarvankar | 55 | 2015 | Independent Director |
Srivardhan Ashwani Khemka | 28 | 2022 | Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review